The effects of protein corona on in vivo fate of nanocarriers
Qingqing Xiao(China Pharmaceutical University), Wei He(Xiamen University), Chenshi Lin(China Pharmaceutical University), Marwa A. Sallam(Alexandria University), Qiaobing Xu(Tufts University), Min Qiu(Kunming Institute of Botany), Xiaotong Li(China Pharmaceutical University), Chao Teng(Qingdao University of Science and Technology), Makhloufi Zoulikha(China Pharmaceutical University)
Cited by 246
Related Papers
New Approaches to Nanofabrication: Molding, Printing, and Other Techniques
|Chemical Reviews|2005|2k
Preparation of Monodisperse Biodegradable Polymer Microparticles Using a Microfluidic Flow‐Focusing Device for Controlled Drug Delivery
|Small|2009|588
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
|Nature|2017|547
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
|Proceedings of the National Academy of Sciences|2005|536
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|Proceedings of the National Academy of Sciences|2022|495